enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
8.52
-0.37 (-4.16%)
Nov 4, 2024, 4:00 PM EST - Market closed
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $376.72 million as of November 5, 2024. Its market cap has increased by 64.00% in one year.
Market Cap
376.72M
Enterprise Value
143.89M
1-Year Change
64.00%
Ranking
Category
Stock Price
$8.52
Market Cap Chart
Since December 10, 2021, enGene Holdings's market cap has increased from $124.90M to $376.72M, an increase of 201.61%. That is a compound annual growth rate of 46.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 393.10M | 83.61% |
| Dec 29, 2023 | 214.10M | 31.11% |
| Dec 30, 2022 | 163.30M | 30.12% |
| Dec 31, 2021 | 125.50M | 0.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 394.41M |
| Sangamo Therapeutics | 393.54M |
| Organogenesis Holdings | 389.03M |
| Amylyx Pharmaceuticals | 387.47M |
| MaxCyte | 386.08M |
| Enhabit | 382.40M |
| Voyager Therapeutics | 378.46M |
| Cross Country Healthcare | 376.71M |